Often, parental reassurance is the only intervention necessary for these seizures, but pediatricians can prescribe a new, uncomplicated treatment that prevents recurrence.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.